Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 60 | 117 | 0 | 1 | 0 |
| Cost of Goods | 25 | 38 | 0 | 3 | 0 |
| Gross Profit | 35 | 79 | 0 | -2 | 0 |
| Operating Expenses | 545 | 880 | 414 | 534 | 561 |
| Operating Income | -485 | -763 | -414 | -533 | -561 |
| Interest Expense | 129 | 157 | 147 | 134 | 108 |
| Other Income | -128 | 109 | 134 | 15 | 15 |
| Pre-tax Income | -742 | -811 | -427 | -652 | -654 |
| Net Income Continuous | -742 | -811 | -427 | -652 | -654 |
| Net Income | $-742 | $-811 | $-427 | $-652 | $-654 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-404 | $-668 | $-322 | $-471 | $-515 |